As carefully addressed in our protocol, we selected widely recommended practices (‘items‘) considered to be important when conducting or reporting clinical trials and systematic reviews.

Anyone may disagree on what and/or how we are assessing the published articles. It is likely we will be able to improve our methods in the future. Any real advance may come faster when everything is transparent. So, you can go back and forth in our documents to get the best sense of what we are assessing and how we are operating. Have fun!

In this page, you can access:

All items and associated components assessed in randomized clinical trials

Rating criteria for components in randomized clinical trials

All items and associated components assessed in systematic reviews with meta-analyses

Rating criteria for components in systematic reviews with meta-analyses